| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/04/2013 | WO2013049164A1 SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS |
| 04/04/2013 | WO2013047719A1 2-(pyridine-2-yl)pyrimidine-4-amine compound and salt thereof |
| 04/04/2013 | WO2013047601A1 Organic electroluminescence element |
| 04/04/2013 | WO2013046136A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
| 04/04/2013 | WO2013046029A1 Macrocyclic lrrk2 kinase inhibitors |
| 04/04/2013 | WO2013045653A1 Macrocyclic flt3 kinase inhibitors |
| 04/04/2013 | WO2013045607A1 Quinazoline linked heteroaromatic tricycle derivatives as pde10a enzyme inhibitors |
| 04/04/2013 | WO2013045519A1 Derivatives of 6-substituted triazolopyridazines as rev-erb agonists |
| 04/04/2013 | WO2013045516A1 Viral replication inhibitors |
| 04/04/2013 | WO2013045461A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 04/04/2013 | WO2013044891A1 METHOD OF PREPARATION OF ε-2,4,6,8,10,12-HEXANITRO-2,4,6,8,10,12-HEXAAZAISOWURTZITANE WITH REDUCED IMPACT SENSITIVITY |
| 04/04/2013 | WO2013044865A1 Oxazolidinone antibiotics containing fused ring |
| 04/04/2013 | WO2012173689A3 Antimicrobial compounds and methods of making and using the same |
| 04/04/2013 | WO2012170845A3 Metabotropic glutamate receptor 5 modulators and methods of use thereof |
| 04/04/2013 | US20130085278 Methods for the preparation of 5-[2-[7 (trifluoromethyl)-5-[4- (trifluoromethyl)phenyl]pyrazolo [1,5-a]pyrimidin-3-yl]ethynyl]-2-pyridinamine |
| 04/04/2013 | US20130085144 Derivatives of azaindazole or diazaindazole type as medicament |
| 04/04/2013 | US20130085142 SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS |
| 04/04/2013 | US20130085141 SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINE SULFONAMIDES AS CALCIUM CHANNEL BLOCKERS |
| 04/04/2013 | US20130085138 Selective NR2B Antagonists |
| 04/04/2013 | US20130085136 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4-[(DIFLUOROETHYL)PHENYL]-4H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE AND 4-(DIFLUOROETHYL)PHENYL-6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE DERIVATIVES |
| 04/04/2013 | US20130085135 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors |
| 04/04/2013 | US20130085134 Quinoxaline compound |
| 04/04/2013 | US20130085126 Pyrazole compounds |
| 04/04/2013 | US20130085123 Organic compounds |
| 04/04/2013 | US20130081999 Bridged Macrocyclic Module Compositions |
| 04/04/2013 | CA2850350A1 Macrocyclic lrrk2 kinase inhibitors |
| 04/04/2013 | CA2849999A1 Macrocyclic flt3 kinase inhibitors |
| 04/04/2013 | CA2849995A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
| 04/04/2013 | CA2848604A1 Viral replication inhibitors |
| 04/04/2013 | CA2848518A1 Derivatives of 6-substituted triazolopyridazines as rev-erb agonists |
| 04/04/2013 | CA2845191A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 04/03/2013 | CN103025736A Macrocyclic hepatitis c serine protease inhibitors |
| 04/03/2013 | CN103025735A Process for the preparation of 5-substituted-8-alkoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-amines |
| 04/03/2013 | CN103025734A Process for the preparation of the compound osi - 906 |
| 04/03/2013 | CN103025728A 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 04/03/2013 | CN103025724A 哌啶衍生物 Piperidine derivatives |
| 04/03/2013 | CN103025716A Bicyclic compound derivatives and their use as acc inhibitors |
| 04/03/2013 | CN103012428A 4-(five-membered heterocycle pyrimidin/substituted pyridine) amino-1H-3-pyrazolecarboxamide CDK (cyclin dependent kinase)/Aurora dual inhibitor and application thereof |
| 04/03/2013 | CN103012415A Method for preparing copper chlorophyll and sodium salt thereof from silkworm excrement |
| 04/03/2013 | CN103012414A Process for enzymatic preparation of enteromorpha chlorophyll |
| 04/03/2013 | CN103012413A Method for preparing polycyclic fused spiral indoles |
| 04/03/2013 | CN103012412A Separation method of triethylene diamine and ethanolamine azeotrope |
| 04/03/2013 | CN103012411A Method for separating and purifying triethylene diamine by reaction |
| 04/03/2013 | CN103012410A [1,2,4] triazole [4,3-b] sym-tetrazine derivation compound and preparation method thereof |
| 04/03/2013 | CN103012409A Improved method for preparing pyrrolopyrrole-1,4-diketone derivative |
| 04/03/2013 | CN103012408A Synthesis method of epinastine |
| 04/03/2013 | CN103012407A N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides and application of N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides as medicines |
| 04/03/2013 | CN103012378A 3-phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/03/2013 | CN103012376A Amide derivatives |
| 04/03/2013 | CN102260268B Benzylthio acetamido acetylpyrazine triazole derivative as well as preparation thereof and application thereof |
| 04/03/2013 | CN101903391B Process for the preparation of a macrocycle |
| 04/03/2013 | CN101684121B New crystal form of pemetrexed diacid and method for preparing same |
| 04/03/2013 | CN101172104B Processes of making and using pharmaceutical formulations of antineoplastic agents |
| 04/02/2013 | US8410267 Regioselective reduction of fused pyrrolocarbazoles-5,7-diones |
| 04/02/2013 | US8410265 Processes for preparing JAK inhibitors and related intermediate compounds |
| 04/02/2013 | US8410264 Heterocyclic oxime compounds |
| 04/02/2013 | US8410263 High-purity texaphyrin metal complexes |
| 04/02/2013 | US8410130 Synthesis of 8H-3A-aza-cyclopenta [A ]indenes and 5,10-dihydropyrrolo[1,2-B]isoquinolines derivatives and their use as antitumor therapeutic agents |
| 04/02/2013 | US8410119 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/02/2013 | US8410117 Imidazopyrimidine derivatives |
| 04/02/2013 | US8410098 N-{1-[3-(2-ethoxy-5-(4-ethylpiperazinyl)sulfonylphenyl)-4,5-dihydro-5-OXO-1,2,4-triazin-6-yl]ethyl}butyramide, the preparation method and use thereof |
| 04/02/2013 | US8410093 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 04/02/2013 | CA2723222C Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 04/02/2013 | CA2584259C Imidazo-benzodiazepine derivatives |
| 04/02/2013 | CA2564085C Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
| 04/02/2013 | CA2550843C Novel phenylalanine derivatives |
| 04/02/2013 | CA2531759C Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors |
| 04/02/2013 | CA2513881C Immunomodulatory compositions |
| 04/02/2013 | CA2475633C Heteroaryl compounds useful as inhibitors of gsk-3 |
| 03/28/2013 | WO2013043826A1 Tricyclic compounds useful as protein kinase inhibitors |
| 03/28/2013 | WO2013042695A1 Metal porphyrin complex, method for producing same, carbon dioxide immobilization catalyst comprising same, and method for producing cyclic carbonic acid ester. |
| 03/28/2013 | WO2013042006A1 Pyrrolopyrimidine and purine derivatives |
| 03/28/2013 | WO2013041634A1 Substituted imidazopyridazines |
| 03/28/2013 | WO2013041605A1 Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors |
| 03/28/2013 | WO2013041502A1 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals |
| 03/28/2013 | WO2013041176A1 Carbazole derivatives for organic electroluminescence devices |
| 03/28/2013 | WO2013041119A1 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals |
| 03/28/2013 | WO2013016193A3 Activators of class i histone deacetlyases (hdacs) and uses thereof |
| 03/28/2013 | WO2013012915A9 Heterocyclic compounds and uses thereof |
| 03/28/2013 | WO2012173521A3 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon |
| 03/28/2013 | WO2012172438A3 Compositions and methods for modulating a kinase |
| 03/28/2013 | WO2012162580A3 Anti-viral compounds |
| 03/28/2013 | WO2012162269A3 Modular supramolecular approach for co-crystallization of donors and acceptors into ordered networks |
| 03/28/2013 | WO2012160576A3 A process for preparation of meropenem |
| 03/28/2013 | WO2012155066A3 Spiro-oxindole mdm2 antagonists |
| 03/28/2013 | WO2012151512A3 Bromodomain inhibitors and uses thereof |
| 03/28/2013 | US20130079350 Substitute 2-amino-3-(Sulfony)pyrazol[1,5-a]pyramidines - serotonin 5-ht6 receptor antagonists, method for us thereof |
| 03/28/2013 | US20130079335 Benzotriazolodiazepine Compounds Inhibitors Of Bromodomains |
| 03/28/2013 | US20130079324 Pyrrolopyrimidine and purine derivatives |
| 03/28/2013 | US20130079323 Gyrase inhibitors |
| 03/28/2013 | US20130079297 Kinase protein binding inhibitors |
| 03/28/2013 | US20130078306 Medicaments containing vardenafil hydrochloride trihydrate |
| 03/28/2013 | CA2849345A1 Substituted imidazopyridazines |
| 03/28/2013 | CA2849340A1 Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors |
| 03/28/2013 | CA2849087A1 Carbazole derivatives for organic electroluminescent devices |
| 03/28/2013 | CA2847540A1 Pyrrolopyrimidine and purine derivatives |
| 03/28/2013 | CA2846369A1 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals |
| 03/27/2013 | EP2573559A1 Modulation of chemosensory receptors and ligands associated |
| 03/27/2013 | EP2571885A1 Method for purifying a fused pyrrolocarbazole derivative |
| 03/27/2013 | EP2571884A2 Mtor selective kinase inhibitors |